Clinical Trial Update: CBD Oil for Reducing Emotional Impact of COVID-19 [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating CBD oil to reduce emotional impact related to COVID-19 is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Anxiety Disorders
• Depressive Disorders
• Sleep Disorders
• Stress-related Disorders
• Substance Use Disorder

Drugs mentioned

• CBD oil (cannabidiol oil)

Snippet

Sponsor: University of Texas at Austin | Conditions: Anxiety Depression, Alcohol Abuse | Phase 2, Phase 3 | Status: SUSPENDED